Addressing overtreatment in breast cancer

The doctors' dilemma


  • Steven J. Katz MD, MPH,

    Corresponding author
    1. University of Michigan Health System, Ann Arbor, Michigan
    • Corresponding author: Steven J. Katz, MD, MPH, Departments of Medicine and Health Management and Policy, University of Michigan, North Campus Research Complex, 2800 Plymouth Road, Building 16, Room 430W, Ann Arbor, MI 48109-2800; Fax: (734) 936-8944

    Search for more papers by this author
  • Monica Morrow MD

    1. Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York
    Search for more papers by this author


Patients with favorable prognosis of breast cancer are vulnerable to overtreatment because the absolute net benefit of different treatments may be small and difficult to quantify in individual cases. Advances in personalized treatment hold the promise of increasing the certainty of the treatment benefit of different treatments in individual patients, but insufficient attention has been paid to the challenges to treatment decision-making.